Submitted 5 hours ago by scrubbed_in
Revolution Medicines reported practice-changing results for a pancreatic cancer drug at ASCO, targeting a previously difficult-to-drug mechanism involved in the disease.
A community for health content
222 subscribers
100% liked
Submitted by scrubbed_in to Health on 31 May 2026
Created by wellnoted, 3 months ago · stats
© 2026 Topicle Pty Ltd · Made in Melbourne, Australia
Topicle Beta
1 comment
Revolution Medicines reported practice-changing results for a pancreatic cancer drug at ASCO, targeting a previously difficult-to-drug mechanism involved in the disease.